Skip to main content
NANOSONICS LIMITED logo

NANOSONICS LIMITED — Investor Relations & Filings

Ticker · NAN ISIN · AU000000NAN9 LEI · 549300XUBCM70BRANN81 ASX Manufacturing
Open in API
Filings indexed 1,049 across all filing types
Latest filing 2008-10-15 Investor Presentation
Country AU Australia
Listing ASX NAN

About NANOSONICS LIMITED

https://www.nanosonics.com.au

Nanosonics Limited is a medical technology company specializing in the development and commercialization of infection prevention solutions. The company's flagship product, the trophon system, provides automated high-level disinfection (HLD) for ultrasound probes. Utilizing a proprietary hydrogen peroxide mist technology, the trophon device ensures consistent and effective disinfection of both the probe handle and shaft, addressing the risks of cross-contamination in clinical settings. The system is designed to integrate into diagnostic workflows, offering a faster and more environmentally sustainable alternative to traditional manual chemical soaking methods. Nanosonics continues to expand its portfolio with digital traceability tools and audit-ready reporting software to enhance compliance and patient safety across global healthcare facilities.

Recent filings

Filing Released Lang Actions
CEO Presentation to Wilson HTM Conference 16 Oct 2008 25 pages ?Kb
Investor Presentation Classification · 95% confidence The document is a detailed presentation from the Wilsons HTM Life Sciences Investment Conference dated 16th October 2008, featuring the CEO David Radford. It includes company background, key investment highlights, funding details, business metrics, intellectual property, market size, regulatory requirements, launch timeline, distribution channels, manufacturing progress, product pipeline, and future market opportunities. The content is structured as a presentation with slides and images, focusing on financials, strategy, market position, and commercialisation plans. There is no indication that this is an official annual or quarterly report, audit report, or earnings release. It is not a transcript of a call, nor a regulatory filing or voting announcement. The document is clearly an investor-focused presentation given at a conference, matching the definition of an Investor Presentation (IP). The length (15,000 characters) and detailed content support this classification with high confidence.
2008-10-15 English
Approval to Market in Canada 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a company announcement from Nanosonics Limited dated 9 September 2008, reporting the approval from Health Canada to market their Ultrasound Probe Disinfector. It discusses regulatory milestones, market entry plans, and product commercialization timelines. The text is relatively short (3831 characters) and reads as a news or regulatory update rather than a detailed financial or operational report. There are no financial statements, detailed management analysis, or comprehensive report content. It is an announcement about a regulatory approval and commercial update, not a full report or presentation. Therefore, it fits best into the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance updates that do not fit other specific categories.
2008-09-08 English
Confirmation of expiry date of options granted in 2006 2 pages ?Kb
Regulatory Filings Classification · 95% confidence The document is a short announcement from Nanosonics Limited confirming the expiry date of options granted in May 2006. It clarifies the expiry date as 30th September 2008 and addresses a previous omission in documentation. The content is focused on confirming details about option expiry dates and does not contain financial statements, detailed financial data, or comprehensive report content. It is an announcement related to capital instruments (options) but does not report on financing activities like new capital raising or changes in capital structure. Given the nature of the document as a confirmation notice about option expiry dates, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories. The document length is short (2603 characters), and it is not a report or a detailed financial document.
2008-08-21 English
Business review and 4E Statement 5 pages ?Kb
Annual Report Classification · 95% confidence The document is titled '2008 Annual Report and 4E Statement' and is dated 20 August 2008. It includes detailed financial results for the year ended 30 June 2008, including revenue, profit/loss, net tangible assets, and loss per share. It references the audited Annual Report for the year ended 30 June 2008 and includes an Appendix 4E Final Report, which is a regulatory filing related to annual financial results in Australia. The document contains substantive financial data, income statements, balance sheets, cash flow statements, and notes, as well as an auditor's report. The length of the document (9574 characters) and the detailed financial content indicate this is the full annual report rather than just an announcement or summary. Therefore, the document fits the definition of an Annual Report (10-K equivalent). FY 2008
2008-08-20 English
2008 Annual Report 75 pages ?Kb
Annual Report Classification · 98% confidence The document is titled 'annual report 08' and contains detailed sections typical of a full annual report, including a Chairman's Letter, Review of Operations, Directors' Report, Remuneration Report, Auditor's Independence Declaration, Corporate Governance Statement, Financial Report, Directors' declaration, and Independent Auditor's Report. It discusses the company's business overview, product development, regulatory approvals, manufacturing, and financial status for the fiscal year 2008. The length is substantial (15,000 characters), indicating it is the full report rather than a brief announcement or summary. The content and structure align with the definition of an Annual Report (10-K) which covers company activity and full financial performance for the year. FY 2008
2008-08-20 English
Change in Director`s Interest 3 pages ?Kb
Director's Dealing Classification · 100% confidence The document is titled 'Change in Director’s Interests' and references an Appendix 3Y Notice, which is a standard form used in Australian Securities Exchange (ASX) filings to report changes in directors' shareholdings. The content details the acquisition of shares by a director, including the number of shares acquired, the date, and the nature of the transaction (on-market purchase). There is no financial performance data, earnings information, or management discussion. The document is a regulatory announcement specifically about a director's personal share transactions. Therefore, it fits the category of Director's Dealing (DIRS). The document length is 3696 characters, which is consistent with a typical director dealing notice rather than a full report or announcement of a report publication.
2008-08-17 English

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.